Dr. Arpita Mukherjee

About

Immunologist focusing on cancer immunotherapy, immune checkpoint regulation, and T-cell exhaustion, with translational interest in neuroimmune mechanisms.

Employment

• Research Scientist Independent research Scientist
  2024 - 2026

Education

• Shri Venkateshwara University Ph.D
  ? - 2023

Projects & Funding

Projects & funding information is unavailable.

Publications (13)

• Cytokine circuitries as determinants of response, resistance, and toxicity across cancer immunotherapy platforms
  Cytokine & Growth Factor Reviews 2026 DOI: 10.1016/j.cytogfr.2026.07.007
  +Save
• Analytical dissection of CRISPR-Cas9-mediated gene editing fidelity: integrating next-generation bioanalytical platforms for precision immunotherapeutics and rare disease correction
  Journal of Rare Diseases 2026 DOI: 10.1007/s44162-026-00220-3
  +Save
• Next-Gen immunotherapy inhematological malignancies: A systematic review and meta-analysis oftranslational breakthroughs, regulatory milestones, and clinical trial trajectories (2018–2025)
  Oncology and Translational Medicine 2026 DOI: 10.1097/ot9.0000000000000150
  +Save
• Neuroimmune Dysregulation as a Public Health Axis in Neurodegeneration: Decoding Immune Checkpoints, Aging, and Biomarkers in Preclinical Alzheimer's Disease
  Biomedical Research and Therapy 2026 DOI: 10.15419/bmrat.v13i6.1078
  +Save
• Immune checkpoint crosstalk between LAG-3 and CD39/CD73 in glioblastoma: dual-pathway regulation of metabolic exhaustion and therapeutic reversal strategies
  Journal of the Egyptian National Cancer Institute 2026 DOI: 10.1186/s43046-026-00361-y
  +Save
• Dietary modulation of the gut–immune–brain axis: nutritional immunoepigenomics for immune regulation in autoimmunity, cancer, and infection
  Clinical Immunology Communications 2026 DOI: 10.1016/j.clicom.2026.01.004
  +Save
• Gut barrier integrity and systemic immunity: Mechanisms linking microbiota, barrier dysfunction, and extra-intestinal disease
  Clinical Immunology Communications 2026 DOI: 10.1016/j.clicom.2026.04.003
  +Save
• LAG-3 as a dual-modulator of neuroimmune surveillance and α-synuclein propagation in Parkinson’s disease and Lewy body dementia
  Discover Neuroscience 2026 DOI: 10.1186/s13064-026-00259-4
  +Save
• The maternal–infant microbiome axis as an epigenetic and immunometabolic orchestrator: redefining early-life programming and precision interventions for lifelong women’s and children’s health
  Infection and Immunity 2026 DOI: 10.1128/iai.00502-25
  +Save
• Immune checkpoint blockade in glioblastoma: overcoming barriers through mechanism-informed, biomarker-guided, and combinatorial immunotherapies targeting the tumor microenvironment and validated by clinical trials
  Oncology and Translational Medicine 2025 DOI: 10.1097/ot9.0000000000000120
  +Save